Double redirects

This page lists pages that redirect to other redirect pages. Each row contains links to the first and second redirect, as well as the target of the second redirect, which is usually the "real" target page to which the first redirect should point. Crossed out entries have been solved.

Showing below up to 50 results in range #1,701 to #1,750.

1701. Unstable angina and complications of bleeding and transfusion prevention → Unstable angina / non ST elevation myocardial infarction complications of bleeding and transfusion prevention → Unstable angina non ST elevation myocardial infarction complications of bleeding and transfusion prevention
1702. Unstable angina and complications of bleeding and transfusion prognosis → Unstable angina / non ST elevation myocardial infarction complications of bleeding and transfusion prognosis → Unstable angina non ST elevation myocardial infarction complications of bleeding and transfusion prognosis
1703. Unstable angina and complications of bleeding and transfusion recommendations → Unstable angina / non ST elevation myocardial infarction complications of bleeding and transfusion recommendations → Unstable angina non ST elevation myocardial infarction complications of bleeding and transfusion recommendations
1704. Unstable angina / NSTEMI direct thrombin inhibitors therapy → Unstable angina / non ST elevation myocardial infarction direct thrombin inhibitors therapy → Unstable angina non ST elevation myocardial infarction direct thrombin inhibitors therapy
1705. Non ST Elevation Myocardial Infarction: Epidemiology and Demographics → Unstable angina / non ST elevation myocardial infarction epidemiology and demographics → Unstable angina non ST elevation myocardial infarction epidemiology and demographics
1706. Unstable Angina / Non ST Elevation Myocardial Infarction: Epidemiology and Demographics → Unstable angina / non ST elevation myocardial infarction epidemiology and demographics → Unstable angina non ST elevation myocardial infarction epidemiology and demographics
1707. Unstable angina epidemiology and demographics → Unstable angina / non ST elevation myocardial infarction epidemiology and demographics → Unstable angina non ST elevation myocardial infarction epidemiology and demographics
1708. Unstable angina / NSTEMI factor Xa inhibitors therapy → Unstable angina / non ST elevation myocardial infarction factor Xa inhibitors therapy → Unstable angina non ST elevation myocardial infarction factor Xa inhibitors therapy
1709. The Living Guidelines: UA/NSTEMI Recommendations for Immediate Management View the Current CLASS I Guidelines → Unstable angina / non ST elevation myocardial infarction immediate management#ACC / AHA Guidelines (DO NOT EDIT) → Unstable angina non ST elevation myocardial infarction immediate management
1710. The Living Guidelines: UA/NSTEMI Recommendations for Immediate Management View the Current CLASS IIa Guidelines → Unstable angina / non ST elevation myocardial infarction immediate management#ACC / AHA Guidelines (DO NOT EDIT) → Unstable angina non ST elevation myocardial infarction immediate management
1711. Non ST elevation myocardial infarction immediate management → Unstable angina / non ST elevation myocardial infarction immediate management → Unstable angina non ST elevation myocardial infarction immediate management
1712. UA/NSTEMI inhibitors of RAS → Unstable angina / non ST elevation myocardial infarction inhibitors of RAS → Unstable angina non ST elevation myocardial infarction inhibitors of RAS
1713. The Living Guidelines: UA/NSTEMI Recommendations for Initial Conservative vs Initial Invasive Strategies View the Current CLASS I Guidelines → Unstable angina / non ST elevation myocardial infarction initial conservative versus initial invasive strategies#ACC / AHA Guidelines (DO NOT EDIT) → Unstable angina non ST elevation myocardial infarction initial conservative versus initial invasive strategies
1714. The Living Guidelines: UA/NSTEMI Recommendations for Initial Conservative vs Initial Invasive Strategies View the Current CLASS IIb Guidelines → Unstable angina / non ST elevation myocardial infarction initial conservative versus initial invasive strategies#ACC / AHA Guidelines (DO NOT EDIT) → Unstable angina non ST elevation myocardial infarction initial conservative versus initial invasive strategies
1715. The Living Guidelines: UA/NSTEMI Recommendations for Initial Conservative vs Initial Invasive Strategies View the Current CLASS III Guidelines → Unstable angina / non ST elevation myocardial infarction initial conservative versus initial invasive strategies#ACC / AHA Guidelines (DO NOT EDIT) → Unstable angina non ST elevation myocardial infarction initial conservative versus initial invasive strategies
1716. The Living Guidelines: UA/NSTEMI Recommendations for Beta Blockers Therapy View the Current CLASS I Guidelines → Unstable angina / non ST elevation myocardial infarction long-term medical therapy and secondary prevention → Unstable angina non ST elevation myocardial infarction long-term medical therapy and secondary prevention
1717. The Living Guidelines: UA/NSTEMI Recommendations for Beta Blockers Therapy View the Current CLASS IIa Guidelines → Unstable angina / non ST elevation myocardial infarction long-term medical therapy and secondary prevention → Unstable angina non ST elevation myocardial infarction long-term medical therapy and secondary prevention
1718. The Living Guidelines: UA/NSTEMI Recommendations for Inhibition of the Renin-Angiotensin-Aldosterone System View the Current CLASS I Guidelines → Unstable angina / non ST elevation myocardial infarction long-term medical therapy and secondary prevention → Unstable angina non ST elevation myocardial infarction long-term medical therapy and secondary prevention
1719. The Living Guidelines: UA/NSTEMI Recommendations for Inhibition of the Renin-Angiotensin-Aldosterone System View the Current CLASS IIa Guidelines → Unstable angina / non ST elevation myocardial infarction long-term medical therapy and secondary prevention → Unstable angina non ST elevation myocardial infarction long-term medical therapy and secondary prevention
1720. The Living Guidelines: UA/NSTEMI Recommendations for Inhibition of the Renin-Angiotensin-Aldosterone System View the Current CLASS IIb Guidelines → Unstable angina / non ST elevation myocardial infarction long-term medical therapy and secondary prevention → Unstable angina non ST elevation myocardial infarction long-term medical therapy and secondary prevention
1721. The Living Guidelines: UA/NSTEMI Recommendations for Nitroglycerin Therapy View the Current CLASS I Guidelines → Unstable angina / non ST elevation myocardial infarction long-term medical therapy and secondary prevention → Unstable angina non ST elevation myocardial infarction long-term medical therapy and secondary prevention
1722. The Living Guidelines: UA/NSTEMI Recommendations for Calcium Channel Blockers Therapy View the Current CLASS I Guidelines → Unstable angina / non ST elevation myocardial infarction long-term medical therapy and secondary prevention → Unstable angina non ST elevation myocardial infarction long-term medical therapy and secondary prevention
1723. The Living Guidelines: UA/NSTEMI Recommendations for Warfarin Therapy View the Current CLASS I Guidelines → Unstable angina / non ST elevation myocardial infarction long-term medical therapy and secondary prevention → Unstable angina non ST elevation myocardial infarction long-term medical therapy and secondary prevention
1724. The Living Guidelines: UA/NSTEMI Recommendations for Warfarin Therapy View the Current CLASS IIb Guidelines → Unstable angina / non ST elevation myocardial infarction long-term medical therapy and secondary prevention → Unstable angina non ST elevation myocardial infarction long-term medical therapy and secondary prevention
1725. The Living Guidelines: UA/NSTEMI Recommendations for Lipid Management View the Current CLASS I Guidelines → Unstable angina / non ST elevation myocardial infarction long-term medical therapy and secondary prevention → Unstable angina non ST elevation myocardial infarction long-term medical therapy and secondary prevention
1726. The Living Guidelines: UA/NSTEMI Recommendations for Lipid Management View the Current CLASS IIa Guidelines → Unstable angina / non ST elevation myocardial infarction long-term medical therapy and secondary prevention → Unstable angina non ST elevation myocardial infarction long-term medical therapy and secondary prevention
1727. The Living Guidelines: UA/NSTEMI Recommendations for Lipid Management View the Current CLASS IIb Guidelines → Unstable angina / non ST elevation myocardial infarction long-term medical therapy and secondary prevention → Unstable angina non ST elevation myocardial infarction long-term medical therapy and secondary prevention
1728. The Living Guidelines: UA/NSTEMI Recommendations for Blood Pressure Control View the Current CLASS I Guidelines → Unstable angina / non ST elevation myocardial infarction long-term medical therapy and secondary prevention → Unstable angina non ST elevation myocardial infarction long-term medical therapy and secondary prevention
1729. The Living Guidelines: UA/NSTEMI Recommendations for Diabetes Mellitus Management View the Current CLASS I Guidelines → Unstable angina / non ST elevation myocardial infarction long-term medical therapy and secondary prevention → Unstable angina non ST elevation myocardial infarction long-term medical therapy and secondary prevention
1730. The Living Guidelines: UA/NSTEMI Recommendations for Smoking Cessation Management View the Current CLASS I Guidelines → Unstable angina / non ST elevation myocardial infarction long-term medical therapy and secondary prevention → Unstable angina non ST elevation myocardial infarction long-term medical therapy and secondary prevention
1731. The Living Guidelines: UA/NSTEMI Recommendations for Weight Management Management View the Current CLASS I Guidelines → Unstable angina / non ST elevation myocardial infarction long-term medical therapy and secondary prevention → Unstable angina non ST elevation myocardial infarction long-term medical therapy and secondary prevention
1732. The Living Guidelines: UA/NSTEMI Recommendations for Physical Activity View the Current CLASS I Guidelines → Unstable angina / non ST elevation myocardial infarction long-term medical therapy and secondary prevention → Unstable angina non ST elevation myocardial infarction long-term medical therapy and secondary prevention
1733. The Living Guidelines: UA/NSTEMI Recommendations for Physical Activity View the Current CLASS IIb Guidelines → Unstable angina / non ST elevation myocardial infarction long-term medical therapy and secondary prevention → Unstable angina non ST elevation myocardial infarction long-term medical therapy and secondary prevention
1734. The Living Guidelines: UA/NSTEMI Recommendations for Patient Education View the Current CLASS I Guidelines → Unstable angina / non ST elevation myocardial infarction long-term medical therapy and secondary prevention → Unstable angina non ST elevation myocardial infarction long-term medical therapy and secondary prevention
1735. The Living Guidelines: UA/NSTEMI Recommendations for Influenza Vaccination View the Current CLASS I Guidelines → Unstable angina / non ST elevation myocardial infarction long-term medical therapy and secondary prevention → Unstable angina non ST elevation myocardial infarction long-term medical therapy and secondary prevention
1736. The Living Guidelines: UA/NSTEMI Recommendations for Depression View the Current CLASS IIa Guidelines → Unstable angina / non ST elevation myocardial infarction long-term medical therapy and secondary prevention → Unstable angina non ST elevation myocardial infarction long-term medical therapy and secondary prevention
1737. The Living Guidelines: UA/NSTEMI Recommendations for Non steroidal Anti-Inflammatory Drugs Use View the Current CLASS I Guidelines → Unstable angina / non ST elevation myocardial infarction long-term medical therapy and secondary prevention → Unstable angina non ST elevation myocardial infarction long-term medical therapy and secondary prevention
1738. The Living Guidelines: UA/NSTEMI Recommendations for Non steroidal Anti-Inflammatory Drugs Use View the Current CLASS IIa Guidelines → Unstable angina / non ST elevation myocardial infarction long-term medical therapy and secondary prevention → Unstable angina non ST elevation myocardial infarction long-term medical therapy and secondary prevention
1739. The Living Guidelines: UA/NSTEMI Recommendations for Non steroidal Anti-Inflammatory Drugs Use View the Current CLASS IIb Guidelines → Unstable angina / non ST elevation myocardial infarction long-term medical therapy and secondary prevention → Unstable angina non ST elevation myocardial infarction long-term medical therapy and secondary prevention
1740. The Living Guidelines: UA/NSTEMI Recommendations for Non steroidal Anti-Inflammatory Drugs Use View the Current CLASS III Guidelines → Unstable angina / non ST elevation myocardial infarction long-term medical therapy and secondary prevention → Unstable angina non ST elevation myocardial infarction long-term medical therapy and secondary prevention
1741. The Living Guidelines: UA/NSTEMI Recommendations for Hormone Therapy View the Current CLASS III Guidelines → Unstable angina / non ST elevation myocardial infarction long-term medical therapy and secondary prevention → Unstable angina non ST elevation myocardial infarction long-term medical therapy and secondary prevention
1742. The Living Guidelines: UA/NSTEMI Recommendations for Antioxidant Vitamins and Folic Acid Use View the Current CLASS III Guidelines → Unstable angina / non ST elevation myocardial infarction long-term medical therapy and secondary prevention → Unstable angina non ST elevation myocardial infarction long-term medical therapy and secondary prevention
1743. Unstable angina / non ST elevation myocardial infarction beta blocker therapy → Unstable angina / non ST elevation myocardial infarction long-term medical therapy and secondary prevention → Unstable angina non ST elevation myocardial infarction long-term medical therapy and secondary prevention
1744. Unstable angina / non ST elevation myocardial infarction inhibition of the renin-angiotensin-aldosterone system → Unstable angina / non ST elevation myocardial infarction long-term medical therapy and secondary prevention → Unstable angina non ST elevation myocardial infarction long-term medical therapy and secondary prevention
1745. Unstable angina / non ST elevation myocardial infarction nitroglycerin therapy → Unstable angina / non ST elevation myocardial infarction long-term medical therapy and secondary prevention → Unstable angina non ST elevation myocardial infarction long-term medical therapy and secondary prevention
1746. Unstable angina / non ST elevation myocardial infarction calcium channel blocker therapy → Unstable angina / non ST elevation myocardial infarction long-term medical therapy and secondary prevention → Unstable angina non ST elevation myocardial infarction long-term medical therapy and secondary prevention
1747. Unstable angina / non ST elevation myocardial infarction warfarin therapy → Unstable angina / non ST elevation myocardial infarction long-term medical therapy and secondary prevention → Unstable angina non ST elevation myocardial infarction long-term medical therapy and secondary prevention
1748. Unstable angina / non ST elevation myocardial infarction lipid managment → Unstable angina / non ST elevation myocardial infarction long-term medical therapy and secondary prevention → Unstable angina non ST elevation myocardial infarction long-term medical therapy and secondary prevention
1749. Unstable angina / non ST elevation myocardial infarction blood pressure control → Unstable angina / non ST elevation myocardial infarction long-term medical therapy and secondary prevention → Unstable angina non ST elevation myocardial infarction long-term medical therapy and secondary prevention
1750. Unstable angina / non ST elevation myocardial infarction diabetes mellitus management → Unstable angina / non ST elevation myocardial infarction long-term medical therapy and secondary prevention → Unstable angina non ST elevation myocardial infarction long-term medical therapy and secondary prevention